Price
$142.47+6.43%Social Signal Score
Analyst Ratings
42 analystsRevenue
$1.87B-85.64%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Lori D. Koch
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 15,000
- Beta
- 1.08
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 0.58
Financials
Revenue
$1.87B-85.6%Net Income
$123.00M+132.1%EBITDA
$474.00M-39.1%Free Cash Flow
$287.00M-70.3%EPS (diluted)
$0.91Shares Outstanding (diluted)
135.10M+9.9%Operating Expenses
$302.00MCash & Debt
$1.65BReturn of Capital
$416.00MRevenue by Segment (annual)
$12.39BDividend per Share
$0.60Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.85B | $-779.00M | $-5.61 |
| 2024 | $12.39B | $703.00M | $5.04 |
| 2023 | $12.07B | $423.00M | $2.82 |
| 2022 | $13.02B | $5.87B | $34.89 |
| 2021 | $12.57B | $6.47B | $35.76 |
| 2020 | $14.34B | $-2.95B | $-12.03 |
| 2019 | $21.51B | $497.00M | $2.01 |
| 2018 | $22.59B | $3.83B | $14.94 |
| 2017 | $62.48B | $1.45B | $8.28 |
| 2016 | $48.15B | $4.30B | $32.13 |
| 2015 | $48.71B | $7.63B | $58.05 |
| 2014 | $58.08B | $3.75B | $26.19 |
| 2013 | $57.02B | $4.75B | $33.48 |
| 2012 | $56.79B | $1.17B | $6.39 |
Valuation
DDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-16.67%Social Signal Score
Mentions (40)
- Newszacks.com·4d ago·Neutral
DuPont Advances Water Treatment With First U.S. OxyMem Installation DD expands its water treatment portfolio with the first U.S. municipal OxyMem installation, targeting nutrient removal, energy savings and future demand growth.
View source ↗ - Newsprnewswire.com·5d ago·Positive
DuPont announces first OxyMem™ MABR installation in the United States The Windsor Water Reclamation Facility (WRF) in California will become the first plant in the United States to utilize DuPont™ OxyMem™ MABR modules WILMINGTON, Del., Nov. 17, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that OxyMem™ membrane aerated biofilm reactor (MABR) modules have been selected for an upgrade to the Windsor Water Reclamation Facility (WRF) in Windsor, California.
View source ↗ - Newsbusinesswire.com·9d ago·Positive
Wolters Kluwer Announces DuPont as Winner of 2026 Legal Innovator Award HOUSTON--(BUSINESS WIRE)--Wolters Kluwer Legal & Regulatory's ELM Solutions business today announced DuPont as the recipient of its 2026 Legal Innovator Award. Recognizing organizations that have transformed legal operations through innovation, operational excellence, and visionary leadership, the award was presented during ELM Solutions user conference, Amplify 2026. "DuPont exemplifies how legal data can be leveraged as a
View source ↗ - News (Marketaux)insidermonkey.com·10d ago·Positive
DuPont (DD): Semiconductor Water Demand Offers Growth Amid Middle East Delays We just published the list of the 10 Bes[+199 characters]
View source ↗ - News (RSS)channelnewsasia·11d ago·Positive
Dupont to play at flyhalf for France against South Africa
View source ↗ - Newsprnewswire.com·13d ago·Neutral
…ands flow capacity and configuration options for industrial and microelectronics water treatment systems WILMINGTON, Del., Nov. 9, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of four new high-flow DuPont™ Electrodeionization (EDI) modules, expanding its portfolio for deionized (DI) water applications in industrial markets and selected ultrapure water (UPW) applications in the microelectronics industry.
View source ↗ - Newsmarketbeat.com·18d ago·Positive
DuPont de Nemours Q3 Earnings Call Highlights DuPont de Nemours NYSE: DD reported third-quarter 2026 results above its prior guidance, citing broad-based sales growth, productivity gains and higher margins. The company raised its full-year outlook for organic sales growth, operating EBITDA and adjusted earnings per share while outlining further share repurchases.
View source ↗ - News (RSS)seekingalpha·19d ago·Positive
DuPont de Nemours, Inc. (DD) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)investing·19d ago·Neutral
Why is DuPont stock surging today?
View source ↗ - News (RSS)cnbc·19d ago·Positive
Why we're keeping a hold rating on DuPont despite its beat-and-raise quarter The stock could beat its February record high close.
View source ↗ - Newsfool.com·19d ago·Negative
Why DuPont Stock Trounced the Market on Tuesday It delivered growth on both the top and bottom lines for the period. It topped analyst estimates for both line items.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
DuPont de Nemours, Inc. (DD) Q3 2026 Earnings Call Transcript DuPont de Nemours, Inc. ( DD ) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Company Participants Ann Giancristoforo - VP of Investor Relations, Corporate FP&A, Strategic Finance Lori Koch - CEO & Director Antonella Franzen - Senior VP & CFO Conference Call Participants Jeffrey Sprague - Vertical Research Partners, LLC Scott Davis - Melius Research LLC Joseph Ritchie - Goldman Sachs Group, Inc., Research Division John McNulty - B…
View source ↗ - News (RSS)economictimes·19d ago·Positive
DuPont raises annual profit forecasts on strong healthcare, aerospace demand DuPont has raised its full-year profit forecasts and projected fourth-quarter earnings exceed analyst estimates. The company experienced strong demand in healthcare, aerospace, and industrial water markets during the third quarter. DuPont's healthcare and water technologies segment reported nearly 4% growth year-over-year, reaching $865 million in net sales. Additionally, the company recently concluded a $250 million sh
View source ↗ - News (Marketaux)rttnews.com·19d ago·Neutral
DuPont Boosts FY26 Outlook As Q3 Swings To Profit While reporting financial results for th[+233 characters]
View source ↗ - Newszacks.com·19d ago·Positive
DD Q3 Earnings Beat on Organic Growth, Raises 2026 Outlook DuPont beats Q3 earnings estimates on strong organic growth, raises its 2026 outlook and plans more buybacks.
View source ↗ - Newswsj.com·19d ago·Negative
DuPont Swings to a Profit and Lifts Outlook DuPont swung to a third-quarter profit of $123 million, or 91 cents a share, from a loss of $123 million, or 88 cents a share, a year earlier.
View source ↗ - Newsreuters.com·19d ago·Positive
DuPont raises full-year profit forecasts on strong healthcare, aerospace demand DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
View source ↗ - Newsprnewswire.com·19d ago·Neutral
…rchases in the third quarter Announces intent to repurchase $250 million of shares in the fourth quarter WILMINGTON, Del., Nov. 3, 2026 /PRNewswire/ -- DuPont (NYSE: DD) announced its financial results(1) for the third quarter ended September 30, 2026 and again raised financial guidance for the full year 2026.
View source ↗ - Newsprnewswire.com·24d ago·Neutral
DuPont Net-Zero Climate Targets Validated by Science Based Targets initiative SBTi validation recognizes DuPont's continued climate progress, with new 2035 emissions-reduction targets and a 2050 net-zero target WILMINGTON, Del., Oct. 29, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its net-zero science-based greenhouse gas (GHG) emissions reduction targets have been validated by the Science Based Targets initiative (SBTi).
View source ↗ - Newszacks.com·30d ago·Neutral
DuPont Expands Bioprocessing Portfolio With New Chromatography Media DD expands its bioprocessing portfolio with AmberChrom SIL silica gel, targeting high-purity peptide purification amid growing demand for GLP-1 therapeutics.
View source ↗ - News247wallst.com·33d ago·Negative
A 30.9% Yield Looks Incredible. The Dividend Math Tells Another Story Six industrial giants are selling off divisions while keeping payouts high, and the cash flow numbers behind those yields tell a very different story than the headline percentages suggest.
View source ↗ - Newszacks.com·34d ago·Positive
DD Gains on Innovation, Productivity and Strategic Acquisitions DuPont's innovation investments, healthcare acquisitions and productivity gains support growth as it raises 2026 earnings guidance amid persistent cost pressures.
View source ↗ - Newsprnewswire.com·40d ago·Negative
DuPont Announces Regular Quarterly Dividend on Common Stock WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 15, 2026, to holders of record of said stock at the close of business on November 30, 2026.
View source ↗ - Newsprnewswire.com·47d ago·Neutral
DuPont Schedules Third Quarter 2026 Earnings Conference Call WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.
View source ↗ - Newszacks.com·51d ago·Neutral
DuPont Expands Sugar Separation Expertise With New Digital Tool DD launches a digital tool using chromatography data to help sugar and sweetener makers assess separation options and identify resins.
View source ↗ - News (RSS)seekingalpha·59d ago·Neutral
DuPont: Secular Growth And Margin Expansion Should Drive Good Upside
View source ↗ - Newsseekingalpha.com·59d ago·Positive
DuPont: Secular Growth And Margin Expansion Should Drive Good Upside DuPont is rated Buy, offering secular growth and margin expansion at an attractive valuation, with strong exposure to healthcare, water, EV, and aerospace markets. Healthcare and Water Technologies drive structural growth, supported by leading positions in medical devices and semiconductor water treatment, with resilient recurring revenues. The Diversified Industrials segment benefits from EV battery adhesives and aerospace, wi
View source ↗ - Newsgurufocus.com·60d ago·Negative
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reductio
View source ↗ - News (Finnhub)CNBC·65d ago·Positive
What it will take for us to buy the dip in DuPont. Plus, profit-taking hits cyber stocks Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
View source ↗ - Newszacks.com·66d ago·Positive
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now DD's innovation, acquisitions and productivity gains support growth, but uneven construction demand and higher input costs weigh on margins.
View source ↗ - Newszacks.com·67d ago·Negative
DuPont Expands Tyvek Portfolio With Lower-Carbon Material Innovation DD expands Tyvek with Renewable Attribution globally, helping C&I customers cut product carbon footprints without redesigning processes.
View source ↗ - News (RSS)guardian·68d ago·Positive
3M, DuPont and more to face lawsuit on Pfas in US firefighters’ protective gear Connecticut plaintiffs say ‘forever chemicals’ in turnout gear increase risk of cancer by absorption and inhalationA federal judge on Tuesday said more than 20 defendants including 3M, DuPont and Honeywell must face claims by Connecticut firefighters who said their protective gear was contaminated by toxic “forever chemicals” that increased their risk of cancer.Lawyers for 13 firefighter union organizations and 1
View source ↗ - News (RSS)investing·68d ago·Neutral
3M, DuPont must face Connecticut firefighters’ lawsuit over ’forever chemicals’
View source ↗ - Newsreuters.com·68d ago·Neutral
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals' A federal judge on Tuesday said more than 20 defendants including 3M , DuPont and Honeywell must face claims by Connecticut firefighters who said their protective gear was contaminated by toxic "forever chemicals" that increased their risk of cancer.
View source ↗ - News (RSS)seekingalpha·73d ago·Neutral
DuPont, Chemours, Corteva reach $455M North Carolina 'forever chemicals' settlement
View source ↗ - News (RSS)investing·73d ago·Neutral
DuPont settles North Carolina PFAS claims for $455 million
View source ↗ - Newsglobenewswire.com·94d ago·Neutral
Flow Cleanrooms & Supply Expands Availability of DuPont™ Tyvek® IsoClean® and Dupont™ Tyvek® 400 Garments Flow Cleanrooms & Supply expands availability of DuPont™ Tyvek® cleanroom garments for contamination control in critical manufacturing environments.
View source ↗ - Newszacks.com·97d ago·Positive
DD's MemCor MBR System Chosen for Major Plant Upgrade in Australia DuPont's MemCor MBR system will add about 97 million liters per day of treatment capacity in Canberra as wastewater demand rises with population growth.
View source ↗ - Newsprnewswire.com·103d ago·Positive
Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion The Lower Molonglo Water Quality Control Center will become the largest MBR plant in Australia with the addition of a new DuPont™ MemCor™ MBR system WILMINGTON, Del., Aug. 11, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that a MemCor™ membrane bioreactor (MBR) system has been selected to support the upgrade of the Lower Molonglo Water Quality Control Centre (LMWQCC) in Canberra, Australia
View source ↗ - Newsreuters.com·107d ago·Neutral
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also known as “forever chemicals.”
View source ↗
Earnings
Tue, Feb 9(in 3 months)
Consensus estimate $1.92 per share
Typical surprise +11.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 3$2.09 vs $1.87beat
- Tue, Aug 4$1.88 vs $1.76beat
- Tue, May 5$1.65 vs $0.49beat
- Tue, Feb 10$1.38 vs $1.29beat
- Thu, Nov 6$3.27 vs $0.47beat
- Tue, Aug 5$0.47 vs $0.45beat
Estimates and results for DD via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DD officers and directors.
- Bought
- —
- Sold
- $20.5m
0 trades
10 trades
- Hoover Erik T.sold
- Koch Lorisold
- Breen Edward Dsold
- Koch Lorisold
- Hoover Erik T.sold
- Koch Lorisold
- Larrabee Steven P.sold
- Larrabee Steven P.sold
90 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Sep 7, 2026 (52d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Feb 13, 2026 (35d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Dec 15, 2025 (33d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (39d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 10, 2025 (26d later)Sell$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed Apr 14, 2025 (14d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (12d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (22d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (26d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (26d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2023 (33d later)Buy$1,001 - $15,000
- Lois Frankelhouse · FL22 · disclosed Oct 10, 2023 (32d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (35d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (27d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (30d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (34d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (28d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
